Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

China's Changing Drug Market In The Wake Of Essential Drugs List

Sep 09 2009

• By PharmAsia News

Related Content

Under New CEO, Glaxo Will Leverage OTCs In Emerging Markets

May 05 2008

Sanofi-Aventis Sees Diversifying In China As Key To Success; Expands Capacity For Diabetes Treatment Lantus

Apr 26 2009

Roche China R&D Center Chief Scientific Officer Li Chen On Being a Pioneer in China: An Interview With PharmAsia News (Part 1 of 2)

Aug 25 2009

Second Part Of Essential Drug List Will Cover More Therapeutic Areas, Says China's Minister Of Health

Aug 25 2009

China’s Essential Drug System Expected To Consolidate Generic Industry, Promote Innovative R&D

May 27 2009

Despite Inclusion Of Generics On China's Essential Drug List, Simcere's Leadership Will Keep Focus On Innovative Drugs

Aug 26 2009

China Releases First Part Of Essential Drug List For Community Health Clinics And Rural Hospitals

Aug 19 2009

New Vaccine Partnership With GSK Could Act As Lifeline For Chinese Biotech Firm Neptunus, Which Has Been Trapped In Troubled Financial Seas

Jun 11 2009

American Oriental Bioengineering Lands 61 Products On China's Essential Drug List; Innovative R&D Still Best Bet

Sep 07 2009

China Simplifies New Registration Provisions For Technology Transfers; Move Will Benefit MNCs

Sep 02 2009

Sandoz Declines To Confirm Plans To Set Up New HQ In Western China

Jul 06 2009

Vaccine Market Will Lead Pharmaceutical Industry In China And Globally, Frost & Sullivan Predicts

Jul 07 2009

More from Archive

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window